Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas
Status:
Completed
Trial end date:
2006-08-09
Target enrollment:
Participant gender:
Summary
This study is designed to investigate the difference in speed and degree of symptom
resolution between daptomycin and vancomycin in subjects treated for cellulitis or erysipelas
by evaluation of the following parameters:
- Time to erythema margin cessation to progress
- Time to defervescence
- Time to hospital discharge following relief of the presenting cellulitis or erysipelas
- Degree of improvement of the following signs and symptom of cellulitis or erysipelas
including
- Degree of improvement of cellulitis-related pain and swelling as reported by subjects
Additionally, the difference in frequency of Adverse Events between daptomycin and vancomycin
will be described.